Advocacy intelligence hub — real-time data for patient organizations
GELLC (Grupo Español de Leucemia Linfocítica Crónica) — PHASE2
University of Birmingham — PHASE2
Dana-Farber Cancer Institute — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs